Diabetes Mellitus and Heart Failure
- Cardio
- 05/06/2017
Considering current trial results, patients with diabetes and heart failure may benefit most from glucose-lowering therapies with sodium glucose cotransporter 2 (SGLT2) inhibition, according to a...
READ MORE